Alnylam Pharmaceuticals | ALNY - Mitarbeiter Gesamtzahl

Aktienkurs
301.30
Täglich Wechseln
-0.81 -0.27%
Monatlich
-4.68%
Jährlich
14.46%
Q2 Prognose
299.00




Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
Arrowhead Research 711 102 2025-12
BioCryst Pharmaceuticals 536 5 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Moderna 5.8K 200 2024-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis 101.7K 2.62K 2022-12
PTC Therapeutics 939 49 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Sangamo BioSciences 405 73 2023-12
Sanofi EUR 91.57K 3.87K 2022-12
Sarepta Therapeutics 1.37K 58 2024-12
Takeda 47.46K 1.83K 2025-12
Tectonic Therapeutic 45 1 2023-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12
Xencor 250 30 2024-12